Clinical trial
Safety of Maraviroc for Post-stroke Depression (Proof-of-concept)
NCT05932550 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of Maraviroc for Post-stroke Depression (Proof-of-concept)
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 4, 2020
- Completion date
- August 4, 2022
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post-stroke depression